Krka, d. d. (WSE:KRK)
900.00
+66.00 (7.91%)
Jul 25, 2025, 5:00 PM CET
Krka, d. d. Revenue
Krka, d. d. had revenue of 526.43M EUR in the quarter ending June 30, 2025, with 8.29% growth. This brings the company's revenue in the last twelve months to 1.97B, up 5.41% year-over-year. In the year 2024, Krka, d. d. had annual revenue of 1.91B with 5.71% growth.
Revenue (ttm)
1.97B EUR
Revenue Growth
+5.41%
P/S Ratio
3.02
Revenue / Employee
174.45K EUR
Employees
11,308
Market Cap
25.24B PLN
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.91B | 103.15M | 5.71% |
Dec 31, 2023 | 1.81B | 88.94M | 5.18% |
Dec 31, 2022 | 1.72B | 151.65M | 9.69% |
Dec 31, 2021 | 1.57B | 30.86M | 2.01% |
Dec 31, 2020 | 1.53B | 41.53M | 2.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NEUCA | 12.82B |
Voxel | 556.98M |
Synektik Spólka Akcyjna | 592.94M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |
EMC Instytut Medyczny | 836.81M |